| Jacinda Elyse Siberio, MD | |
|
5109 36th Ave N, Crystal, MN 55422-2007 | |
| (763) 587-7900 | |
| (763) 587-7989 |
| Full Name | Jacinda Elyse Siberio |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 5109 36th Ave N, Crystal, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083904049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 60168 (Wisconsin) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 59435 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Memorial Health | Robbinsdale, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Clinic Pa | 2769384205 | 51 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
The American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines has approved and issued several updates to clinical practice guidelines for the treatment of osteoarthritis (OA).
Prior Scientific announces world class warranty for their best in Class Products. Our new improved warranty for motorized stages is five (5) years from the date of purchase only when used with a Prior controller, for controllers three (3) years and for Prior Scientific's custom-built products one (1) year.
› Verified 3 days ago
| Entity Name | North Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114962206 PECOS PAC ID: 2769384205 Enrollment ID: O20040123000954 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
The American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines has approved and issued several updates to clinical practice guidelines for the treatment of osteoarthritis (OA).
Prior Scientific announces world class warranty for their best in Class Products. Our new improved warranty for motorized stages is five (5) years from the date of purchase only when used with a Prior controller, for controllers three (3) years and for Prior Scientific's custom-built products one (1) year.
› Verified 3 days ago
| Entity Name | Planned Parenthood Mn, Nd, Sd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629057146 PECOS PAC ID: 6002709631 Enrollment ID: O20040206000003 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
The American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines has approved and issued several updates to clinical practice guidelines for the treatment of osteoarthritis (OA).
Prior Scientific announces world class warranty for their best in Class Products. Our new improved warranty for motorized stages is five (5) years from the date of purchase only when used with a Prior controller, for controllers three (3) years and for Prior Scientific's custom-built products one (1) year.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacinda Elyse Siberio, MD 9201 West Broadway Ave, Suite 601, Brooklyn Park, MN 55445 Ph: (763) 587-7900 | Jacinda Elyse Siberio, MD 5109 36th Ave N, Crystal, MN 55422-2007 Ph: (763) 587-7900 |
News Archive
Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted oncolytic virus therapeutics, today announced that the European Medicines Agency (EMEA) has granted Orphan Drug Designation to Jennerex's product JX-594 for the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. JX-594 is expected to enter a Phase 3 pivotal trial in the second half of 2010.
When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.
The American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines has approved and issued several updates to clinical practice guidelines for the treatment of osteoarthritis (OA).
Prior Scientific announces world class warranty for their best in Class Products. Our new improved warranty for motorized stages is five (5) years from the date of purchase only when used with a Prior controller, for controllers three (3) years and for Prior Scientific's custom-built products one (1) year.
› Verified 3 days ago
Dr. Caitlin Ruth Kuck, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5109 36th Ave N, Crystal, MN 55422 Phone: 763-587-7900 Fax: 763-587-7989 | |
Dr. Jon S Nielsen, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5700 Bottineau Blvd, 210, Crystal, MN 55429 Phone: 763-587-7000 Fax: 763-587-7015 | |
Dr. James R Krause, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5700 Bottineau Blvd, #210, Crystal, MN 55429 Phone: 763-587-7000 Fax: 763-587-7015 | |
Dr. Christine Marie Sarkinen, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5700 Bottineau Blvd, #210, Crystal, MN 55429 Phone: 763-587-7000 Fax: 763-587-7015 | |
Dr. Sarah Manalansan Manneh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5700 Bottineau Blvd, #210, Crystal, MN 55429 Phone: 763-587-7000 Fax: 763-587-7015 | |
Dr. Matthew Michael Palmer, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5700 Bottineau Blvd, Suite 210, Crystal, MN 55429 Phone: 763-587-7000 Fax: 763-587-7015 |